Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Use of Machine Learning Techniques to Classify Neurodegenerative PARKinsonian Syndromes (Artificial Intelligence)

NCT05080296 is registered in ClinicalTrials.gov with Central Hospital, Nancy, France as lead sponsor.

NCT NCT05080296
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05080296 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Use of Machine Learning Techniques to Classify Neurodegenerative PARKinsonian Syndromes (Artificial Intelligence)
Lead sponsor
Central Hospital, Nancy, France
Phase
Observational
Overall status
Completed
Start date
December 20, 2021
Completion date
September 1, 2024
Enrollment
1,664 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

datscan spect scans